EYPT — EyePoint Pharmaceuticals, Inc. stock price, charts and financials

QT23EyePoint Pharmaceuticals, Inc.

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
11.67
-0.75-6.04%
OverviewShort InterestFilings
EYPTQT23EyePoint Pharmaceuticals, Inc.·NASDAQ
11.67-6.04%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 31, 2026SC 13GBeneficial ownership statement (passive)
Jul 30, 20268-KCurrent report
Jul 28, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 17, 20268-KCurrent report
Jul 14, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jun 22, 20268-KCurrent report
May 27, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 14, 20268-KCurrent report
May 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 07, 202610-QQuarterly report
May 06, 20268-KCurrent report
Apr 27, 2026DEFA14AAdditional proxy soliciting materials
Apr 27, 2026DEF 14ADefinitive proxy statement
Apr 20, 20264Statement of changes in beneficial ownership
Apr 13, 20268-KCurrent report
Mar 26, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 24, 20264Statement of changes in beneficial ownership
Mar 20, 20268-KCurrent report
Mar 16, 20264Statement of changes in beneficial ownership
Mar 06, 20264Statement of changes in beneficial ownership
Mar 05, 20264Statement of changes in beneficial ownership
Mar 05, 202610-KAnnual report
Mar 04, 20268-KCurrent report
#1 / 25 of 421
Page
▼
/ 17